Two recent studies conducted in HIV-positive cohorts found that immune defects as measured by a lower CD4 T cell count may be associated with a decline in FEV1 and FVC [34] and COPD [35]. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.